TrialBlood advances2025

Impact of prior CAR T-cell therapy on mosunetuzumab efficacy in patients with relapsed or refractory B-cell lymphomas.

Elise A Chong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.